Tianhong Hang Seng Shanghai-Shenzhen-H.K Inno Drug Select 50 Index ETF (SHA:517380)
0.8970
-0.0030 (-0.33%)
At close: Sep 22, 2026
SHA:517380 Holdings Information
SHA:517380 is an equity ETF with a total of 88 individual holdings. The top holdings are WuXi AppTec stock at 19.60%, Jiangsu Hengrui Pharmaceuticals Co.,Ltd at 12.96%, BeOne Medicines AG at 12.51%, WuXi Biologics at 7.08%, and Innovent Biologics at 6.83%.
Total Holdings
88
Top 10 Percentage
67.44%
Asset Class
Equity
ETF Category
Health Care
Assets
n/a
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | SHA: 603259 | WuXi AppTec Co., Ltd. | 15.72% |
| 2 | SHA: 600276 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 12.96% |
| 3 | HKG: 6160 | BeOne Medicines AG | 10.76% |
| 4 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 7.08% |
| 5 | HKG: 1801 | Innovent Biologics, Inc. | 6.83% |
| 6 | HKG: 2359 | WuXi AppTec Co., Ltd. | 3.88% |
| 7 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 2.93% |
| 8 | SHE: 002422 | Sichuan Kelun Pharmaceutical Co., Ltd. | 2.59% |
| 9 | HKG: 1177 | Sino Biopharmaceutical Limited | 2.37% |
| 10 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 2.33% |
| 11 | SHE: 002821 | Asymchem Laboratories (Tianjin) Co., Ltd. | 2.11% |
| 12 | HKG: 1530 | 3SBio Inc. | 1.79% |
| 13 | SHA: 688235 | BeOne Medicines AG | 1.75% |
| 14 | SHA: 600196 | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1.71% |
| 15 | SHE: 300759 | Pharmaron Beijing Co., Ltd. | 1.67% |
| 16 | SHA: 688331 | RemeGen Co., Ltd. | 1.53% |
| 17 | SHE: 300347 | Hangzhou Tigermed Consulting Co., Ltd | 1.49% |
| 18 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 1.48% |
| 19 | HKG: 2228 | XtalPi Holdings Limited | 1.46% |
| 20 | n/a | Cash | 1.40% |
| 21 | SHA: 688266 | Suzhou Zelgen Biopharmaceuticals Co., Ltd. | 1.39% |
| 22 | SHE: 000963 | Huadong Medicine Co., Ltd | 1.33% |
| 23 | SHA: 688180 | Shanghai Junshi Biosciences Co., Ltd. | 1.17% |
| 24 | SHE: 002653 | Haisco Pharmaceutical Group Co., Ltd. | 1.11% |
| 25 | SHE: 002294 | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 0.96% |
As of Jun 30, 2026